comparemela.com

Latest Breaking News On - Forefront analytics - Page 7 : comparemela.com

Athira Pharma (NASDAQ:ATHA) Earns Market Outperform Rating from JMP Securities

JMP Securities reaffirmed their market outperform rating on shares of Athira Pharma (NASDAQ:ATHA – Free Report) in a research note released on Thursday morning, Benzinga reports. JMP Securities currently has a $19.00 price objective on the stock. Athira Pharma Price Performance Shares of ATHA stock opened at $2.52 on Thursday. Athira Pharma has a 1 […]

Athira-pharma
Advisor-group
Forefront-analytics
Laird-norton-trust-company
Athira-pharma-company-profile
Clarius-group
Athira-pharma-inc
Free-report
Get-free-report
Capital-partners
Norton-trust-company
Athira-pharma-daily

JMP Securities Reaffirms "Market Outperform" Rating for Athira Pharma (NASDAQ:ATHA)

JMP Securities reiterated their market outperform rating on shares of Athira Pharma (NASDAQ:ATHA – Free Report) in a report issued on Thursday morning, Benzinga reports. The brokerage currently has a $19.00 price target on the stock. Athira Pharma Price Performance Athira Pharma stock opened at $2.52 on Thursday. The stock’s 50 day moving average is […]

Athira-pharma
Laird-norton-trust-company
Forefront-analytics
Athira-pharma-inc
Advisor-group
Clarius-group
Free-report
Get-free-report
Capital-partners
Norton-trust-company
Athira-pharma-daily

HC Wainwright Analysts Increase Earnings Estimates for Annexon, Inc. (NASDAQ:ANNX)

Annexon, Inc. (NASDAQ:ANNX – Free Report) – Research analysts at HC Wainwright lifted their Q2 2024 earnings estimates for Annexon in a report issued on Tuesday, May 14th. HC Wainwright analyst A. Fein now expects that the company will post earnings per share of ($0.22) for the quarter, up from their prior forecast of ($0.37). […]

United-states
America
Kennedy-capital-management
Sg-americas-securities
Annexon-inc
Annexon-company-profile
Wells-fargo-company
Sectoral-asset-management-inc
Jpmorgan-chase-co
Cantor-fitzgerald
Silverarc-capital-management

Annexon (NASDAQ:ANNX) Given "Buy" Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Annexon (NASDAQ:ANNX – Free Report) in a report issued on Tuesday, Benzinga reports. The firm currently has a $30.00 price target on the stock. HC Wainwright also issued estimates for Annexon’s Q2 2024 earnings at ($0.22) EPS, Q3 2024 earnings at ($0.23) EPS, Q4 2024 earnings […]

United-states
America
Sectoral-asset-management-inc
Sg-americas-securities
Wells-fargo-company
Kennedy-capital-management
Annexon-inc
Forefront-analytics
Jpmorgan-chase-co
Cantor-fitzgerald
Needham-company

Annexon (NASDAQ:ANNX) Earns "Buy" Rating from Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of Annexon (NASDAQ:ANNX – Free Report) in a research report report published on Monday morning, Benzinga reports. They currently have a $16.00 target price on the stock. Other equities research analysts also recently issued research reports about the stock. HC Wainwright reissued a buy rating […]

United-states
America
Sg-americas-securities
Wells-fargo-company
Needham-company
Forefront-analytics
Ameritas-investment-partners-inc
Jpmorgan-chase-co
Annexon-inc
Cantor-fitzgerald
Annexon-company-profile

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.